Clinical Trial for Lung Cancer.

The purpose of this study is to learn about dacomitinib for the possible treatment of lung cancer.

This study is seeking participants who:

have lung cancer that could not be controlled.
have a type of gene called epidermoid growth factor receptor. A gene is a part of your DNA that has instructions for making things your body needs to work.
have received dacomitinib for their lung cancer.

All participants in this study had received dacomitinib. Dacomitinib is a tablet that is taken by mouth at home. They continued to take dacomitnib until their cancer was no longer responding. The study will look at the experiences of people receiving the study medicine. This will help to see if the study medicine is safe and effective.

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Lung Cancer

Sex

Male or Female

Age

18+ years

View more eligibility criteria on ClinicalTrials.gov

A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

Who may participate

View locations for this study

Nearest Locations found

A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

Who may participate

View locations for this study

Nearest Locations found

Are you a Healthcare Professional?